Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mirogabalin and Pain After Total Hip Arthroplasty: a Double-blind, Randomized, Placebo-controlled Trial

NCT05938088 is registered in ClinicalTrials.gov with Gangnam Severance Hospital as lead sponsor.

NCT NCT05938088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05938088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mirogabalin and Pain After Total Hip Arthroplasty: a Double-blind, Randomized, Placebo-controlled Trial
Lead sponsor
Gangnam Severance Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
July 20, 2023
Completion date
June 28, 2025
Enrollment
56 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hip osteoarthritis